Schirrmacher
Impact in
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
Papers in
- Immunology 11
- Immunotherapy and Immune Responses 8
- Oncology 10
- Cancer Immunotherapy and Biomarkers 4
- Cancer Cells and Metastasis 2
- CAR-T cell therapy research 2
- Co-authors
- Hans Wigzell (3 shared papers)Israël Vlodavsky (2 shared papers)Zvi Fuks (1 shared paper)Yafa Ariav (1 shared paper)Elke Lang (1 shared paper)D. Komitowski (1 shared paper)D. Kramer (1 shared paper)Georg Brunner (1 shared paper)
- Journals
- International Journal of Oncology (3 papers)International Journal of Oncology (2 papers)Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (21 papers)
- Partner nations
- GermanyItalyUnited States
In The Last Decade
Schirrmacher
28 papers receiving 356 citations
Peers
Comparison fields: 5 of 61
- Immunology 180
- Immunology and Allergy 36
- Animal Science and Zoology 53
- Genetics 131
- Oncology 106
Countries citing papers authored by Schirrmacher
This map shows the geographic impact of Schirrmacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Schirrmacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Schirrmacher more than expected).
Fields of papers citing papers by Schirrmacher
This network shows the impact of papers produced by Schirrmacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Schirrmacher. The network helps show where Schirrmacher may publish in the future.
Co-authors
The 25 scholars most cited alongside Schirrmacher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 68 | |
| 2 | Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance. | 1983 | 40 |
| 3 | Changes in tumor cell adhesiveness affecting speed of dissemination and mode of metastatic growth. | 1988 | 38 |
| 4 | Immune responses against native and chemically modified albumins in mice. II. Effect of electric charge and conformation on the humoral antibody response and on helper T cell responses. | 1974 | 33 |
| 5 | 1992 | 29 | |
| 6 | Plasmin in pericellular proteolysis and cellular invasion. | 1995 | 28 |
| 7 | Immunity and metastasis: in situ activation of protective T cells by virus modified cancer vaccines. | 1992 | 21 |
| 8 | 2009 | 17 | |
| 9 | Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response. | 1981 | 17 |
| 10 | Polarization of human monocyte-derived dendritic cells to DC1 by in vitro stimulation with Newcastle Disease Virus. | 2009 | 16 |
| 11 | Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. III. Postoperative activation of tumor-specific CTLP from mice with metastases requires stimulation with the specific antigen plus additional signals. | 1989 | 14 |
| 12 | Tumor immunology: Paul Ehrlich's heritage. | 1989 | 12 |
| 13 | 2010 | 8 | |
| 14 | Clonal analysis of H-2 antigen expression by variants of a chemically induced murine tumor. | 1981 | 6 |
| 15 | Foreign H-2-like molecules on a murine tumor (MCG4): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus-specific CTL. | 1980 | 6 |
| 16 | Affinity fractionation of lymphoid cells according to type and function. | 1972 | 5 |
| 17 | Cytotoxic immune cells with specificity for defined soluble antigens. 3. Separation from helper cells and from antibody-forming cell precursors. | 1973 | 5 |
| 18 | 2010 | 5 | |
| 19 | Isolation and characterization of a metastatic Eb-like tumor variant highly responsive to interleukin (IL)-2 and to combination cytokine therapy with IL-2/IL-1 beta and IL-1 beta/interferon-alpha/beta. | 1993 | 4 |
| 20 | [Adjuvant therapy of liver metastases: active specific immunotherapy]. | 1995 | 4 |
About Schirrmacher
Schirrmacher is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 28 papers that have together received 388 indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Immunotherapy and Immune Responses (8 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Cancer Research and Treatments (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Cells and Metastasis (2 papers), CAR-T cell therapy research (2 papers) and Glycosylation and Glycoproteins Research (2 papers). The work is most often cited by research in Immunology (180 citations), Immunology and Allergy (36 citations), Animal Science and Zoology (53 citations), Genetics (131 citations) and Oncology (106 citations). Schirrmacher has collaborated with scholars based in Germany, Italy and United States. Frequent co-authors include Hans Wigzell, Israël Vlodavsky, Zvi Fuks, Yafa Ariav, Elke Lang, D. Komitowski, D. Kramer, Georg Brunner, Philippe Fournier and Anne‐Sophie Arnold. Their work appears in journals such as International Journal of Oncology, International Journal of Oncology, Zentralblatt für Chirurgie - Zeitschrift für Allgemeine Viszeral- Thorax- und Gefäßchirurgie, Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.